SOURCE: Implant Sciences Corporation

Implant Sciences Corporation

July 10, 2012 07:00 ET

Implant Sciences Joins Airforwarders Association

WILMINGTON, MA--(Marketwire - Jul 10, 2012) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, announced today that it has become a member of the Airforwarders Association (AfA), an alliance of Indirect Air Carriers, Cargo Airlines, and affiliated businesses located throughout the global transportation community. The Airforwarders Association serves as the voice of the airforwarding industry, advocating for its members and providing information and education to the air and expedited freight forwarding industry.

"Implant Sciences' equipment is already being used for air cargo screening in Europe and Asia. Working with industry organizations like the Airforwarders Associations will help the Company grow this business," stated Glenn D. Bolduc, President and CEO of Implant Sciences. "We look forward to opportunities to build awareness of Implant Sciences' products, to shape future air cargo regulations, and to help increase air cargo security worldwide, all of which AfA membership will foster."

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company's QS-B220 desktop explosives and drugs trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608
    Email Contact